Anne Reiser - ResMed Insider

RMD -- USA Stock  

USD 104.18  1.61  1.57%

  President
Ms. Anne Reiser is President Europe Asia Pacific of Resmed Inc. Ms. Reiser was appointed president of our Europe and Asia Pacific region in December 2014. Previously, Ms. Reiser was president of ResMeds Europe region, a position she began in March 2012. She served as our chief operating officer France beginning in 2007, after joining as the sales director in 2006. Before joining ResMed, her career experience was in the medical device industry . More recently she worked for Medtronic and Hollister, with responsibilities for both France and finally southern European countries
Age: 54  President Since 2014      
858-836-5000  http://www.resmed.com
Reiser has a master degree from Ecole Sup?rieure de Commerce de ClermontFd, and a bachelor degree of law from the University of ClermontFerrand and an executive master in management and healthcare policies from SciencesPo Paris.

Anne Reiser Latest Insider Activity

Management Efficiency

The company has Return on Asset of 11.28 % which means that on every $100 spent on asset it made $11.28 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 16.97 % implying that it generated $16.97 on every 100 dollars invested.
The company has 529.61 M in debt with debt to equity (D/E) ratio of 27.8 . This implies that the company may be unable to create cash to meet all of its financial commitments. ResMed has Current Ratio of 2.53 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

MICHAEL TRIPLETTCigna Corporation
2017
Lonny CarpenterStryker Corporation
2009
Chris TothVarian Medical Systems
2018
Mark DoakAgilent Technologies
2014
Bronwen TaylorStryker Corporation
2013
Deborah RasinDENTSPLY SIRONA
2011
John DerenTeleflex Incorporated
2017
Alicia RodriguezAgilent Technologies
N/A
Ulrich MichelDENTSPLY SIRONA
2016
Dominique GrauAgilent Technologies
2014
Nicholas AlexosDENTSPLY SIRONA
2017
Kolleen KennedyVarian Medical Systems
2018
Robert McMahonAgilent Technologies
2018
David GuilmetteCigna Corporation
2012
William McDowellCigna Corporation
2015
Matthew MandersCigna Corporation
N/A
Patrick KaltenbachAgilent Technologies
2014
Katherine OwenStryker Corporation
2007
Albert SterkenburgDENTSPLY SIRONA
2009
Graham McleanStryker Corporation
2017
Jacob ThaysenAgilent Technologies
2018

Entity Summary

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and is traded on New York Stock Exchange. It employs 6000 people.ResMed (RMD) is traded on New York Stock Exchange in USA. It is located in 9001 Spectrum Center Boulevard and employs 6,000 people.

ResMed Leadership Team

John Wareham, Independent Director
Ronald Taylor, Lead Independent Director
Rob Douglas, President COO
Christopher Roberts, Independent Director
Gary Pace, Independent Director
Chris Roberts, Independent Director
Robert Douglas, Pres and COO
Agnes Lee, Senior Director - Investor Relations
Carol Burt, Independent Director
Rich Sulpizio, Independent Director
Peter Farrell, Non-Executive Chairman of the Board
Jim Hollingshead, President - Americas
Brett Sandercock, CFO and Principal Accounting Officer
Ron Taylor, Lead Independent Director
Don Darkin, President - Sleep-disordered Breathing Strategic Business Unit
Jack Wareham, Independent Director
Anne Reiser, President Europe
Karen Drexler, Director
Raj Sodhi, President ? Software as a Service (SaaS) Business and CTO
David Pendarvis, Chief Admin. Officer, Global General Counsel and Secretary
Richard Sulpizio, Independent Director
Michael Farrell, CEO and Director
Richard McHale, President ? Respiratory Care
Donald Darkin, President ? innovation & operations

Stock Performance Indicators

Current Sentiment - RMD

ResMed Investor Sentiment

Greater number of Macroaxis users are at this time bullish on ResMed. What is your perspective on investing in ResMed? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip
Currently Active Assets on Macroaxis
F   
Purchased over 300 shares of
a day ago
Traded for 9.31
VMW   
Purchased a lot of shares of
a day ago
Traded for 154.28
FB   
Purchased over 20 shares of
a day ago
Traded for 132.81
TWTR   
Purchased over 90 shares of
a day ago
Traded for 31.98
MSFT   
Purchased over 20 shares of
a day ago
Traded for 105.01
Additionally take a look at Your Equity Center. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com